申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0131302A2
公开(公告)日:1985-01-16
The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.
所述咪唑盐可用作抗心律失常药物。本文提供了一种通过增加心脏组织的折射性来治疗心律失常的方法,以及含有此类咪唑鎓盐的药物制剂。